Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

cyclopia sequence 6Prostatic Neoplasms 6Neoplasm Metastasis 6Breast Neoplasms 6Lung Neoplasms 4Dyspnea 4Recurrence 3Primary Myelofibrosis 3Oropharyngeal Neoplasms 3Multiple Myeloma 3Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Squamous Cell Carcinoma of Head and Neck 2Polycythemia Vera 2Pain 2Kidney Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Thrombocythemia, Essential 1Splenomegaly 1Speech 1Sezary Syndrome 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plexosarcoma 1Pathologic Complete Response 1

Interventions

Cyclophosphamide 14fludarabine 12fludarabine phosphate 8Melphalan 8Brentuximab Vedotin 8Whole-Body Irradiation 7Mycophenolic Acid 7Busulfan 7Rituximab 6Tacrolimus 5Lenalidomide 4Etoposide 4isatuximab 3Sirolimus 3Mesna 3Granulocyte Colony-Stimulating Factor 3Dexamethasone 3pembrolizumab 2nilotinib 2dacetuzumab 2Vincristine 2Thiotepa 2Sugars 2Stem Cell Transplantation 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Ondansetron 2N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 2Methotrexate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hematologic Diseases × Surveys and Questionnaires × Clear all
NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed
52 enrolled 13 charts
Other

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡